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Genetic interaction (GI) maps, comprising pairwise
measures of how strongly the function of one gene
depends on the presence of a second, have enabled
the systematic exploration of gene function in micro-
organisms. Here, we present a two-stage strategy to
construct high-density GI maps in mammalian cells.
First, we use ultracomplex pooled shRNA libraries
(25 shRNAs/gene) to identify high-confidence hit
genes for a given phenotype and effective shRNAs.
We then construct double-shRNA libraries from
these to systematically measure GIs between hits.
A GI map focused on ricin susceptibility broadly
recapitulates known pathways and provides many
unexpected insights. These include a noncanonical
role for COPI, a previously uncharacterized protein
complex affecting toxin clearance, a specialized
role for the ribosomal protein RPS25, and func-
tionally distinct mammalian TRAPP complexes. The
ability to rapidly generate mammalian GI maps
provides a potentially transformative tool for defining
gene function and designing combination therapies
based on synergistic pairs.
INTRODUCTION
Analysis of mammalian genomic sequences provides a parts list
of the proteins that comprise a cell. The remaining challenge is to
define functions for these parts and understand how they act
together. Work in model organisms, especially budding yeast,
has demonstrated the broad utility of comprehensive genetic
interaction (GI) maps in defining gene function in a systematicand unbiased manner (Collins et al., 2009; Dixon et al., 2009).
GIs, which measure the extent to which the phenotype of a first
mutation is modified by the presence of a second, reveal func-
tional relationships between genes. Additionally, the pattern of
GIs of a gene provides an information-rich description of its
phenotype, which can be used to detect functional similarities
between genes and reveal pathways without prior assumptions
about cellular functions.
Systematic quantitative analysis of GIs in yeast has allowed
rapid identification of new functional complexes, predicted
roles for uncharacterized genes, revealed network rewiring in
response to environmental changes, and demonstrated func-
tional repurposing of complexes and interactions during evolu-
tion (Bandyopadhyay et al., 2010; Collins et al., 2009; Dixon
et al., 2009; Frost et al., 2012). More recently, GI maps have
also been used with great success in Gram-negative bacteria,
fission yeast, and cultured cells from fruit flies (Butland et al.,
2008; Frost et al., 2012; Horn et al., 2011; Ryan et al., 2012;
Typas et al., 2008).
In mammalian cells, an approach for systematic mapping of
GIs could have broad utility for unbiased functional annotation
of the human genome as well as for targeted investigation of
mammalian-specific pathways. More generally, a better under-
standing of the structure of GIs may clarify the complex herita-
bility of common traits (Zuk et al., 2012). Furthermore, GIs are
important in both the pathogenesis and treatment of a number
of human diseases, such as cancer (Ashworth et al., 2011). For
example, pairs of genes that exhibit synthetic lethality in cancer
cells, but not healthy cells, are ideal targets for combination
therapies aimed at limiting the emergence of drug resistance in
rapidly evolving cells.
A number of challenges confront any effort to systematically
quantify GIs. First, high-precision phenotypic measurements
are needed to accurately determine GIs, which are quantified
as the deviation of an observed double-mutant phenotypeCell 152, 909–922, February 14, 2013 ª2013 Elsevier Inc. 909
from that expected from two individual mutants. Second, GIs are
typically rare (Collins et al., 2009; Dixon et al., 2009), and
therefore a scalable high-throughput approach is required to
generate large, high-density GI maps. At the same time, the large
number of possible pairwise interactions in the human genome
(4 3 108) makes it necessary to focus on a subset of genes
with common biological functions to create a sufficiently dense
GI map to reveal meaningful insights.
Recent developments in screening technologies have laid the
groundwork for systematic forward genetics in mammalian cells.
Both short-hairpin RNA (shRNA)-based RNA interference (RNAi)
and haploid insertion approaches lend themselves to pooled
screening, which, when combined with deep-sequencing-based
readouts (Bassik et al., 2009; Carette et al., 2011; Silva et al.,
2008), allows massive multiplexing and provides a controlled,
identical environment for all cells. Nevertheless, the extraction
of robust biological information from genome-wide screening
data is challenging (Kaelin, 2012); for RNAi-based screens in
particular, the problems of false-positive hits caused by off-
target effects and false-negative hits caused by ineffective
RNAi agents can limit reliability. Despite these challenges,
screens for modifiers of single genes have demonstrated the
value of investigating GIs by RNAi (Barbie et al., 2009; Luo
et al., 2009).
We have developed a scalable, high-precision pooled
shRNA-based approach for robustly conducting RNAi-based
screens and measuring GIs in high throughput in mammalian
cells. We used our method to examine genetic modifiers of
cellular susceptibility to ricin. Ricin is a member of a broad class
of AB-type protein toxins that includes major human pathogens.
Similar to many viral pathogens, these toxins enter cells by
endocytosis and hijack intracellular trafficking pathways.
Though medically important in their own right, these agents
have also been used with great success to probe various
aspects of cell biology (Johannes and Popoff, 2008; Spooner
and Lord, 2012). Because the general biology of ricin has
been extensively studied, it is well suited to evaluate screening
approaches. Indeed, several recent screens have been con-
ducted to identify factors whose depletion protects against
AB-toxins (Carette et al., 2009; Guimaraes et al., 2011; Moreau
et al., 2011; Pawar et al., 2011). Nonetheless, a comprehensive
understanding of the pathways exploited by ricin is missing,
and little is known about factors whose loss enhances ricin
toxicity.
In a primary genome-wide screen for modifiers of ricin suscep-
tibility, we found 200 known and previously uncharacterized
factors that either sensitized or protected cells against ricin
intoxication; with some interesting exceptions, these factors
were remarkably well focused on the retrograde transport
pathway. We then defined functional relationships among these
genes in a GI map. We could broadly recapitulate existing
complexes and pathways, functionally dissect multiprotein com-
plexes, identify new complexes with uncharacterized compo-
nents, and provide unexpected insights into the functions of
well-characterized genes. More broadly, this work establishes
a strategy that integrates a robust method for RNAi screening
with scalable, systematic analysis of GIs, which should be appli-
cable to diverse biological problems.910 Cell 152, 909–922, February 14, 2013 ª2013 Elsevier Inc.RESULTS AND DISCUSSION
Strategy for Primary Screens Using Ultracomplex
shRNA Libraries
The first step in our strategy is to conduct a genome-wide screen
to identify genes that function within a biological pathway of
interest and effective shRNAs that target them, using ultracom-
plex shRNA libraries. Ultracomplex libraries increase the likeli-
hood of targeting each gene with several effective shRNAs, thus
reducing the false-negative rate. Additionally, requiring several
active shRNAs to identify a hit gene reduces the rate of false
positives, as it is unlikely that several shRNAs targeting a non-
hit gene have off-target effects relevant to the phenotype of
interest. Two key technical developments enable ultrahigh-
coverage screening: the ability to construct ultracomplex libraries
using massively parallel oligonucleotide synthesis (Cleary et al.,
2004; Silva et al., 2005) and the capacity of deep sequencing to
monitor screening results (Bassik et al., 2009; Silva et al., 2008).
To determine the best design for a genome-wide ultracomplex
shRNA library, we conducted a pilot screen with a limited library
targeting 1,000 genes with 50 shRNAs each. We chose ricin as
a selective agent for our screen because it efficiently kills cells
and relies on numerous host cell factors for its toxicity. In our pilot
library,we includedshRNAs targetinganumberofgenes thatwere
previously reported to affect ricin sensitivity. In addition, we
included more than 1,000 negative control shRNAs that had the
same overall base composition as the other shRNAs in the library
but that did not match the sequence of any human transcript.
We infected K562 human myelogenous leukemia cells with
these libraries and subjected one half of the population to four
pulses of ricin treatment while the other half was grown
in the absence of ricin. After 12 days, genomic DNA was
isolated from cells of the treated and untreated populations,
the shRNA-encoding cassettes were PCR amplified, and their
frequencies were quantified by deep sequencing (Figure 1A).
Comparison of the frequency of each shRNA in the treated and
untreated populations yielded an enrichment ratio. To enable
direct comparisons between different experiments, we defined
a metric r for ricin resistance, which quantifies the differential
effect that an shRNA has on cell growth in the presence versus
absence of ricin (see Extended Experimental Procedures avail-
able online and M.K., M.C.B., and J.S.W., unpublished data).
An shRNA without effect on ricin sensitivity has a r of 0; shRNAs
conferring ricin resistance have positive r values; and shRNAs
sensitizing cells to ricin have negative r values. The criterion
for hit genes was based on a p value, which reports on the prob-
ability that the distribution of rs for all shRNAs targeting a given
gene was significantly different from the distribution for negative
control shRNAs (reflecting both random noise and off-target
effects), as determined by the Mann-Whitney U test (Figure 1B).
The robustness of this approach is supported by the agreement
of hit genes obtained when we constructed and screened two
independent shRNA libraries targeting the same genes but using
different shRNA designs and target sites (Figure S1A).
To identify an appropriate complexity for a genome-wide
library, we examined how the number of shRNAs targeting
each gene affects the confidence of hit detection. Specifically,
we calculated p values based on random subsets of shRNAs
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Figure 1. Pooled High-Coverage RNAi
Screen for Ricin Resistance and Sensiti-
zation
(A) Experimental strategy: A population of K562
cells was infected with a pooled high-cover-
age shRNA library and split into two subpopu-
lations, one of which was treated with ricin.
The frequency of shRNA-encoding constructs in
each subpopulation was determined by deep
sequencing.
(B) Based on the frequency in the treated and
untreated subpopulations, a quantitative resis-
tance phenotype r was calculated for each
shRNA. Comparing the distribution of rs for
shRNAs targeting a gene of interest to the r
distribution for negative control shRNAs using the
Mann-Whitney U test yielded a p value for the
gene. RAB1B knockdown protects cells from ricin
(p = 6.9 3 108), whereas knockdown of COPA
sensitizes cells to ricin (p = 2.4 3 108).
(C and D) Increasing the coverage of the shRNA
library improves the detection of hit genes above
background. p values for each gene in a test library
were calculated on the basis of random subsets
of the data; the number of shRNAs included per
gene was varied. Random subsampling was
repeated 100 times; means of –log10 P values are
shown. Gray dotted lines indicated a coverage of
25 shRNAs per gene, which we chose for our
genome-wide library.
(C) Means of –log10 p values ± SD for three
example genes: a strong hit (RAB1A), a moderate
hit (STX16), and a non-hit (CRYAB).
(D) Means of –log10 p values for all 1,079 genes
targeted by the library (left) and for the top 50 hits
based on the p value calculated from 45 shRNAs
(right).
See also Figure S1.for each gene and determined the effect of subset size on the
p value for three example genes: the strong hit gene RAB1A,
the weaker hit gene STX16, and the non-hit gene CRYAB (Fig-
ure 1C). In our experimental system, the ability to confidently
resolve STX16 from background began at 15 shRNAs per
gene and increased steadily as more shRNAs were included.
These examples are representative of the entire spectrum of
genes (Figure 1D): increasing the coverage of shRNAs per
gene improved the signal for hits without spuriously increasing
p values for non-hits. Based on these results, we chose
a coverage of 25 shRNAs per gene for a genome-wide library.
Reproducibility and Performance of Ultracomplex
Libraries in a Pilot Ricin Screen
To test the ability of our screening approach to identify effective
shRNAs targeting hit genes, we carried out the ricin resistance
pilot screen in duplicate. The quantitative phenotypes of shRNAs
targeting hit genes correlated reasonably well between repli-
cates (Figure S1B). A main source of noise in pooled screens is
thought to be Poisson sampling error, originating from repeated
passaging of cells through a population bottleneck (Pierce et al.,2007). Indeed, conducting a batch retest of shRNAs chosen
based on primary screen results with a coverage of 50,000
cells per shRNA species, as compared with 1,000 cells per
shRNA during the primary screen, strongly suppressed the level
of observed variability (Figure S1C). In future screens, a small-
scale (2 l) bioreactor should allow one to conduct an entire
primary genome-wide screen in a single batch of suspension
cells with 4,000-fold coverage of cells per shRNA.
We validated phenotypes for single shRNAs individually (Fig-
ure S1D) and in a pooled batch retest or individual competitive
growth assays. These two quantitative assays gave highly corre-
lated results (Figure S1E). Generally, the phenotypic strength of
shRNAs targetingagivenhitgenealsocorrelatedwellwith theeffi-
ciency of target mRNA knockdown (Figure S1F), suggesting that
shRNAs were predominantly acting through the intended target.
A Genome-wide, High-Coverage shRNA Screen for
Modifiers of Ricin Toxicity Yields Diverse Hits Focused
on Key Pathways
We next designed a library targeting each annotated human
protein-coding gene with 25 independent shRNAs on average,Cell 152, 909–922, February 14, 2013 ª2013 Elsevier Inc. 911
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Figure 2. Hits from a Genome-wide Screen
Recapitulate Known Ricin Biology
(A) Overview of ricin intoxication of mammalian
cells. Ricin is taken up by endocytosis and traffics
retrogradely to the ER, where ricin A and B chains
dissociate. The A chain retrotranslocates to the
cytoplasm and cleaves ribosomal RNA, thereby
inhibiting protein synthesis and ultimately trig-
gering apoptosis.
(B) GO-term enrichment analysis for top hits. Top
hits were defined as the set of 73 protective genes
with an FDR <0.05 and 83 sensitizing genes with
an FDR <0.02. Nonredundant GO terms with an
FDR <0.05 are shown. (Black bars) biological
process; (gray bars) cellular component.
(C) Visualization of top hits in cellular pathways as
blue circles (protective hits) and red circles (sen-
sitizing hits); circle area is proportional to –log10
p value. Selected hits below the top hit cutoff were
included (pink and light blue circles) if they were
part of a known physical complex containing a top
hit or if they were part of the GI map presented in
Figure 5. Gray ovals indicate known physical
complexes, and the asterisk identifies theWDR11/
C17orf75 complex identified in this study.
See also Figure S2 and Table S1.as well as at least 500 negative control shRNAs per experiment.
The shRNAswere grouped in nine sublibraries of 55,000 shRNAs
each, based on annotated biological functions (Extended
Experimental Procedures).
For our first application of the genome-wide screening
approach, we also used ricin, as it should give access to the
rich biology of host pathways exploited by this toxin (Lord
et al., 2005; Sandvig et al., 2010; Spooner and Lord, 2012).
Specifically, ricin is internalized by endocytosis and traffics retro-
gradely through the secretory pathway to the ER, where its A and
B subunits are dissociated. The catalytic A subunit is then retro-
translocated to the cytoplasm, where it depurinates a single
base in the 28S rRNA, shutting down translation and leading to
apoptosis (Figure 2A).
We defined a set of hit genes based on false discovery rate
(FDR; Storey and Tibshirani, 2003); this set contained the 73
strongest protective hits (FDR <0.05) and the 83 strongest sensi-
tizing hits (FDR <0.02) (Table S1). These hits were strongly
enriched for genes related to trafficking along the secretory
pathway (Figure 2B). Figure 2C displays the top hits in their912 Cell 152, 909–922, February 14, 2013 ª2013 Elsevier Inc.canonical cellular context (see also Fig-
ure S2). A large fraction of characterized
hits included genes either acting in the
secretory pathway or otherwise expected
based on known ricin biology. In addition,
we tagged several poorly characterized
hit genes with GFP, expressed them
from their native chromosomal context
in BACs (Poser et al., 2008), and con-
firmed that they were localized to secre-
tory pathway organelles (Figure S3). We
found that many of the top hits in thescreen are also known to exist in physical complexes with
each other, with strong protection upon knockdown of compo-
nents of COPII, TRAPP, and GARP and strong sensitization
upon knockdown of components of COPI, the ribosome, and
the proteasome. Taken together, the above results illustrate
the specificity and robustness of the hits identified by our
approach.
Consistent with results from previous ricin screens and indi-
vidual gene studies, we found that the early endocytic factors
clathrin and Rab5 (Moreau et al., 2011) were required for ricin
toxicity, as well as STX16, a snare protein involved in vesicle
fusion at the TGN (Amessou et al., 2007). Among the most
strongly enriched were components of the GARP complex
known to be required for tethering endosome-derived vesicles
to the Golgi (Bonifacino and Hierro, 2011). Knockdowns of
several (but not all, see below) components of the vesicle-
tethering TRAPP complex were among the most strongly
protective.
Surprisingly, a large number of components of the COPII
machinery required for anterograde vesicle budding from the
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Figure 3. Characterization of Hit Genes
from the Primary Screen
(A) K562 cells were treated with ricin in the pres-
ence or absence of atorvastatin for 24 hr and were
then allowed to recover in the continued presence
of atorvastatin. The mean percentage of viable
cells in triplicate measurements ± SD was quan-
tified using flow cytometry.
(B) Cells expressing ER-localized SNAP were
intoxicated with benzylguanine-labeled ricin, and
covalent ricin-SNAP complexes were detected by
anti-SNAP western blot.
(C) Quantification of ricin-modified fraction of ER-
SNAP (mean of triplicate experiments ± SD).
(D) Raji B cells were infected with shRNAs target-
ing the indicated genes, and a competitive growth
assaywas performed in the presence of either ricin
or shiga toxin (Stx). Mean of triplicate ricin resis-
tance (r) measurements ± SD is shown.
(E) COPZ1 knockdown increases levels of ER-
localized ricin (mean of triplicate experiments ±
SD), as measured by the SNAP assay.
Error bars represent SD. See also Figure S3.ER were strongly protective against ricin when knocked down,
which has not been previously observed. It is likely that shut-
down of ER-Golgi trafficking (and consequent Golgi collapse)
prevents ER delivery of ricin.
Depletion of ribosomal components and ribosome biogenesis
factors sensitized cells to the toxin, as expected given that ricin
targets the ribosome. A notable exception was RPS25, whose
knockdown was strongly protective against ricin, as discussed
below.
Identification of Atorvastatin as a Small-Molecule
Inhibitor of Ricin Transport to the ER
One goal of RNAi-based forward genetic screens is to identify
therapeutically valuable targets for small-molecule inhibitors.
Consistent with previous studies (Grimmer et al., 2000), our
primary screen identified components of the cholesterol biosyn-
thesis pathway, including HMG-CoA reductase (HMGCR). We
observed a dose-dependent protection of ricin-treated cells by
the HMGCR inhibitor atorvastatin (Figure 3A), confirming the
role of HMGCR in modulating the toxicity of ricin and demon-
strating that our primary screen could identify effective pharma-
cological targets.
To assess whether inhibition of HMGCR by atorvastatin
affected delivery of ricin to the ER, we expressed an ER-targeted
SNAP protein (Geiger et al., 2011) in cells and added benzylgua-
nine (BG)-coupled ricin to measure ricin flux into the ER. Upon
delivery of toxin to the ER, an irreversible bond can form between
ricin-BG and ER-SNAP, which we could quantify as an increase
in molecular weight by western blot (Figure 3B). The fraction
of SNAP that is present in ricin conjugates was reduced
by 80% upon treatment with atorvastatin (Figures 3B and
3C), suggesting that toxin traffic to the ER was blocked upon
HMGCR inhibition.A Paradoxical Role for COPI in Diverting Ricin from
the ER
One of the more surprising results from the primary screen was
a profound sensitization to ricin upon depletion of COPI compo-
nents (Figure 2C and Table S1), which are normally involved in
retrograde endosome-Golgi and Golgi-ER transport (Popoff
et al., 2011). Several groups have observed a lack of requirement
for retrograde COPI components in trafficking of ricin or Shiga
toxin (Chen et al., 2002; Girod et al., 1999; Llorente et al.,
2003). However, sensitization by COPI depletion or inactivation
has not been described previously.
Primary hits from the ricin screen were retested in batch in
a second cell type (Raji B) for their effects on sensitivity to both
ricin and Shiga toxin, a similar AB toxin (data not shown). Again,
we observed sensitization to ricin upon COPI knockdown but
strong protection against Shiga toxin, revealing an unexpected
difference between the trafficking pathways of these two well-
studied toxins. Individual shRNAs targeting COPI components
ARCN1 or COPZ1 confirmed this finding (Figure 3D). This diver-
gent set of requirements was the exception rather than the rule:
ARF1 is a representative factor whose knockdown protected
against both toxins (Figure 3D). COPI depletion enhanced
delivery of toxin to the ER based on the SNAP assay (Figure 3E).
It may be that COPI knockdown upregulates a compensatory
alternative pathway or that it normally functions in transport
steps that divert ricin from the ER.
A Strategy for Generating High-Density GI Maps Based
on Double-shRNA Screens
Though our screen accurately identified genes that are important
for ricin pathology, the large number of hits makes individual vali-
dation and characterization challenging. Indeed, the difficulty in
pinpointing promising hits for in-depth follow up representsCell 152, 909–922, February 14, 2013 ª2013 Elsevier Inc. 913
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Figure 4. Effects of Combinatorial Gene Knockdowns by Double-shRNAs
(A) Experimental strategy: Active shRNAs targeting hit genes from the primary screen were individually cloned, and barcodes were added upstream and
downstream of the miR30 context. Pooled ligation yielded a library of all pairwise combinations of shRNAs. Ricin resistance phenotypes of double-shRNAs were
determined as for the primary screen; double-shRNAs were identified by sequencing the combinatorial barcode (red arrow).
(B) Reproducibility between phenotypes of individual shRNAs in a batch retest (mean of two experiments ± spread) and the same shRNAs paired with negative
control shRNAs in a double-shRNA screen (mean ± SD for combinations with 12 different negative control shRNAs).
(C) Reproducibility between two permutations of double-shRNA constructs representing (negative control + targeted) or (targeted + negative control), mean ±SD
for combinations with 12 different negative control shRNAs.
(legend continued on next page)
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a general bottleneck for the interpretation of RNAi screens.
To address this issue, we developed a strategy to systematically
determine GIs between the hits based on double-knockdown
phenotypes. For this purpose, we created a double-shRNA
library based on effective shRNAs identified from the primary
screen. shRNA-encoding cassettes were individually barcoded,
pooled, and ligated to obtain all pairwise combinations (Figures
4A and S4). This double-shRNA library was introduced into cells
and subjected to a ricin resistance screen under the same condi-
tions as those in the primary screen to quantify double-shRNA
phenotypes.
In order to obtain single-shRNA phenotypes from the same
screen, we included 12 negative control shRNAs in the double-
shRNA library pool. Importantly, phenotypes of single shRNAs
as quantified by batch retest were in excellent agreement with
phenotypes of double shRNAs combining the same shRNAs
with negative control shRNAs (Figure 4B). Moreover, the pres-
ence of a second shRNA and the order of shRNAs within the
double-shRNA construct had minimal impact on the measured
phenotypes (Figure 4C) or knockdown efficiency (Figures S5,
S6D, and S6E).
We found that the typical phenotype of a given double shRNA
could be reliably predicted by a linear relationship of the pheno-
types of the two individual shRNAs (Figure 4D). GIs were thus
quantified as deviations from the linear fit of this typical
double-mutant phenotype. Deviations toward the phenotype of
WT cells were defined as buffering GIs, and deviations away
from WT were defined as synergistic GIs. As expected, two
shRNAs targeting the same gene typically showed buffering
GIs (e.g., SEC23B in Figure 4D), whereas synergistic GIs could
be observed for some shRNAs targeting genes acting in parallel
(e.g., shRNAs targeting SEC23A and SEC23B, two isoforms with
partially distinct functions; Fromme et al., 2008; Schwarz et al.,
2009; Figure 4D). GIs observed in the pooled double-shRNA
screen could also be reproduced in individual validation experi-
ments. For example, SEC23A and SEC23B knockdown (whose
specificity was validated by rescue experiments; Figures S6A–
S6C) synergized to create highly ricin-resistant cells, as moni-
tored by the competitive growth assay (Figure 4E). A similar
synergistic effect was seen when the amount of ricin reaching
the ER was assessed by ER-SNAP assay (Figures 4F and S6F).
Construction and Benchmarking of a Ricin GI Map
A major motivation for systematic GI mapping beyond the direct
analysis of pairwise interactions between genes is the possibility
of analyzing the correlation of global GI patterns between
different genes. Genes with highly correlated GI patterns tend
to be functionally related (Collins et al., 2009; Dixon et al., 2009).
Correlations between shRNA GI patterns derived from our
double-shRNA screens were highly reproducible between inde-(D) Genetic interactions are calculated as deviations from the typical double-muta
shRNA phenotypes in combination with an shRNA of interest (in this example, S
genetic interactions. Buffering interactions (yellow) are closer to WT phenotype th
Synergistic interactions (blue) are further away fromWT than expected, as in this c
SEC23B.
(E) Phenotypes for individual and combinatorial SEC23A, SEC23B knockdown m
(F) Quantification of ER localization of ricin measured by the SNAP assay in diffe
See also Figures S4, S5, and S6.pendent experimental replicates (Figure 5A). As expected,
shRNAs targeting the same gene had more correlated GI
patterns than other shRNAs (Figure 5B), indicating that their
phenotypes were mostly due to on-target knockdown. Similarly,
shRNA pairs targeting different members of the same protein
complex had highly correlated GI patterns, which were clearly
distinct from the bulk of shRNA pairs. This result demonstrates
the ability of our approach to broadly identify genes encoding
members of the same physical complex. Interestingly, shRNAs
targeting a small set of genes produced GI patterns that were
anticorrelated with those targeting other components of the
same physical complex (Figure 5B), causing an overall bimodal
distribution of intracomplex GIs. These genes also had the oppo-
site phenotype in the primary screen: TRAPPC9 (anticorrelated
with other members of the TRAPP complex), SEC23A (anticorre-
lated with other COPII components), and RPS25 (uncorrelated
with ribosomal proteins of the large subunit). The unusual
behavior of these three genes is robustly observed for all three
shRNAs targeting each of them and is therefore likely to reflect
the functional differences. These findings illustrate that our
genetic results can functionally dissect known physical com-
plexes, which we explore below in more detail for RPS25 and
the TRAPP complex.
A possible source of noise in an RNAi-based GI map is the fact
that an effective on-target shRNA can have partial off-target
effects, which can confound its GI pattern. To minimize this
effect, we required each gene in the GI map to be targeted by
at least two (and typically three) shRNAs whose GI patterns
were sufficiently correlated (Extended Experimental Procedures;
M.K., M.C.B., and J.S.W., unpublished data) and averaged the
GIs of these highly correlated shRNAs for each gene. Using
these stringent criteria, the resulting GI map (Figure 5C) encom-
passed pairwise interactions between 60 genes, each repre-
sented by three shRNAs on average, and was based on the
pooled measurement of >36,000 double-shRNA phenotypes.
The main limitation for increasing the scale of GI maps is the
availability of highly validated shRNAs, as a single bioreactor
run can measure >500,000 shRNA pairs.
Functional Predictions from the Ricin GI Map
Hierarchical clustering of genes based on the correlation of their
GIs was remarkably successful at recapitulating a number of
well-characterized complexes, including the COPI and COPII
vesicle coats, clathrin, GARP, and the ribosome, as well as
complexes with unknown roles in ricin biology, such as the cohe-
sins (Figure 5C). In addition, the map demonstrated clustering of
functionally interacting proteins, such as the small GTPase ARF1
and its guanine nucleotide exchange factor GBF1.
The GI map also led to numerous functional predictions, three
of which are highlighted below.nt phenotype. The relationship between single shRNA phenotypes and double-
EC23B_i) is typically linear (red line). Deviations from this line are defined as
an expected, as in this case found for double-shRNAs targeting SEC23B twice.
ase found for double-shRNAs targeting both isoforms of SEC23, SEC23A, and
easured in competitive growth assay (mean of triplicate experiments ± SD).
rent knockdown strains (mean of triplicate experiments ± SD).
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Figure 5. A GI Map Reveals Functionally and Physically Interacting Genes
(A and B) Correlations of GI patterns between shRNA pairs: shRNAs targeting the same gene in orange, shRNAs targeting different genes in previously known
physical complexes in purple, and other pairs of shRNAs in gray.
(A) Reproducibility of GI correlations between shRNA pairs in two experimental replicates.
(B) High intragene and intracomplex correlation of GIs. Distributions of correlation coefficients between shRNA pairs are shown for the three classes of shRNA
pairs. The anticorrelated part of the bimodal distribution of intracomplex shRNA pairs is fully accounted for by pairs including shRNAs targeting TRAPPC9,
SEC23A, and RPS25.
(C) GIs for all gene pairs were calculated (shown as a yellow-cyan heatmap), and genes were clustered hierarchically based on the correlation of their GIs.
Individual phenotypes are indicated by sidebars using a red-blue heatmap. Genes marked with asterisks were imported from a separate double-shRNA screen
that we conducted with a partially overlapping gene set. Gene pairs for which no GIs were measures are indicated in gray. Known physically or functionally
interacting groups of genes are labeled by vertical lines; diamonds mark interactions defined in this study.
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An Unexpected Role for Ribosomal Protein RPS25
Remarkably, we found that RPS25 knockdown conferred ricin
resistance. By contrast, all other ribosomal hits sensitized cells
to ricin, as expected given that ribosome inactivation is the basis
for ricin cytotoxicity. The GI map provided a clue to the divergent
role of RPS25: RPS25 formed a cluster with ILF2 and ILF3 (Fig-
ure 5C). ILF2/3 encode heterodimeric nucleic-acid-binding
proteins with roles in transcription, mRNA stability, and transla-
tional control (Barber, 2009). ILF2/3 knockdown protected
against ricin, and we confirmed that the shRNAs against
RPS25 and ILF2/3 acted through their intended target genes
(Figure S7). As expected for proteins in a physical complex,
shRNAs targeting ILF2 showed buffering GIs with shRNAs
targeting ILF3 (Figures 6A and 6B). Surprisingly, we also
observed very strong buffering interactions between ILF2/3
and RPS25, which was consistent for all combinations of the
nine shRNAs targeting ILF2, ILF3, and RPS25 (Figure 6B).
Previous literature has implicated both RPS25 and ILF2/3 in
translational control: RPS25 has been shown to be required for
translation of IRES-containing mRNAs in cricket paralysis virus
(Landry et al., 2009), whereas ILF2/3 can bind viral IRES and
control translation (Merrill and Gromeier, 2006). Therefore, it is
tempting to speculate that ILF2/3 and RPS25may work together
to control translation of certain transcripts that affect ricin sensi-
tivity, possibly under particular stress conditions.
Identification of the WDR11/C17orf75 Complex
One unexpected prediction was the interaction betweenWDR11
and C17orf75, two poorly characterized genes. Both sensitized
cells to ricin when depleted, exhibited highly correlated profiles
in the GI map, and showed buffering interactions with each
other, which is often a signature for genes encoding proteins in
the same pathway or physical complex. Indeed, we found that
the encoded proteins interacted in reciprocal immunoprecipita-
tion experiments (Figures 6C and 6D).
Previously, WDR11was suggested to interact with a transcrip-
tion factor (Kim et al., 2010), as well as to impact flux through the
autophagy pathway (Behrends et al., 2010). Consistent with the
latter observation, we found that GFP-tagged WDR11 partially
colocalized with the autophagosome marker LC3 (Figure 6E).
This suggests a potential role for WDR11 in toxin degradation.
Indeed, depletion of WDR11 or BECN1, a regulator of auto-
phagy, caused an increase in total cellular ricin (Figure 6F). By
contrast, other genes that sensitized (COPZ1) or protected
(TRAPPC8) cells against ricin had an insignificant effect on total
toxin levels (although they do affect toxin delivery to the ER; Fig-
ure 6G). When degradation pathways are inhibited, more ricin
can enter the productive intoxication pathway (Figure 6H), which
provides a potential explanation for the observed increase in
delivery of toxin to the ER upon depletion ofWDR11 (Figure 6G).
Nonetheless, further study will be required to define the precise
role of this complex.
Functional Dissection of the Mammalian TRAPP
Complex
Two of themost strongly protective hits from our primary screen,
C4orf41 and KIAA1012, were poorly characterized at the onset
of our studies. In our GI map, these genes formed a highly corre-
lated cluster connected by buffering GIs with another poorly
characterized gene, C5orf44, and with TRAPPC1, a member ofthe TRAPP complex, a highly conserved multisubunit complex
involved in ER-Golgi, endosome-Golgi, and autophagosome
transport (Barrowman et al., 2010). Based on this pattern, we
predicted that C4orf41, KIAA1012, and C5orf44 function as
TRAPP complex components. To test this, we GFP tagged and
immunoprecipitated these components (Figures 7A and 7B).
We could identify most TRAPP components described to date,
as well as C5orf44, in both immunoprecipitations. C4orf41 and
KIAA1012 were previously identified as TRAPP3 interactors in
a high-throughput immunoprecipitation study (Gavin et al.,
2002) and, concurrent with our studies, were independently
identified as TRAPP components and designated TRAPPC8
and TRAPPC11, respectively (Scrivens et al., 2011). Additionally,
C5orf44 was recently shown to exhibit homology to yeast Trs65
and to physically interact with other TRAPP components (Choi
et al., 2011). Based on these observations, we designate
C5orf44 as TRAPPC13.
In yeast, several TRAPP complexes have been identified
(Barrowman et al., 2010) with distinct roles in ER-Golgi traffic
(TRAPPI), intra-Golgi and endosome-Golgi traffic (TRAPPII),
and autophagy (TRAPPIII). In mammalian cells, TRAPP has
been suggested to form a single large complex (Scrivens et al.,
2011), and it has been unclear whether this complex is respon-
sible for all observed TRAPP activities.
Our data revealed a clear functional distinction between
different TRAPP components. We found only a subset of TRAPP
components as strongly protective hits, whereas other com-
ponents had either no phenotype or, in the case of TRAPPC9,
were mildly sensitizing (Table S1; Figure S7E). Moreover, the
genetic interaction pattern of TRAPPC9 showed a striking anti-
correlation with other TRAPP components (Figures 7C and
5C), suggesting that complexes containing these proteins are
distinct and have opposing roles in ricin trafficking. Indeed, we
found that immunoprecipitation of either TRAPPC8 or
TRAPPC11 pulled down the COPII components SEC31A and
SEC23IP as well as the other known TRAPP components, with
the prominent exception of TRAPPC9 and TRAPPC10 (Fig-
ure 7D). Similarly, previous immunoprecipitation experiments
found that TRAPPC9 did not recover TRAPPC8 (Zong et al.,
2011). Conversely, we found that immunoprecipitation of
TRAPPC10 pulled down core TRAPP components, but not
TRAPPC8/11/12/13, SEC31, or SEC23IP (Figure 7D). Based on
this, we examined the migration properties of the various TRAPP
components by size exclusion chromatography. These studies
directly established the existence of two physically distinct
complexes: a larger complex containing TRAPPC8 and
TRAPPC11 and a smaller one containing TRAPPC10 (Figure 7E).
To further define mammalian TRAPP complexes, we exam-
ined their interactions with COPII components. The yeast
TRAPPI complex is a COPII-vesicle-tethering factor (Sacher
et al., 2001), and COPII and TRAPPC3 interact in yeast and
mammalian cells (Cai et al., 2007). Consistent with this, GFP-
labeled TRAPPC8 and TRAPPC11 colocalized with SEC31A
(Figure S7F). Our finding that TRAPPC8 and TRAPPC11, but
not TRAPPC10, coimmunoprecipitated the COPII component
SEC31A (Figure 7F) suggests that differential interaction with
COPII may functionally distinguish the two mammalian TRAPP
complexes. Indeed, knockdown of TRAPC11 or TRAPC12, butCell 152, 909–922, February 14, 2013 ª2013 Elsevier Inc. 917
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Figure 6. Interactions Predicted from the GI Map: RPS25/ILF2/3 andWDR11/C17orf75
(A) Buffering genetic interactions between shRNAs targeting ILF3, the ribosomal subunit RPS25, and ILF2/ILF3.
(B) Correlation and buffering genetic interactions between shRNAs targeting ILF2, ILF3, and RPS25 in an shRNA-based genetic interaction map.
(C and D) The poorly characterized, genetically correlated proteins WDR11 and C17orf75 interact physically, as shown by reciprocal coimmunoprecipitation
and MS.
(E) GFP-WDR11 partially colocalizes with the autophagosome/lysosome marker mCherry-LC3 in HeLa cells.
(F) Total cellular ricin levels after intoxication, as quantified by western blotting, are increased upon knockdown of degradation-related genes andWDR11 (which
sensitizes to ricin);meanof triplicate experiments±SD. Theasterisk indicates statistically significant differences (p<0.05,Student’s t test). Error bars represent SD.
(legend continued on next page)
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not TRAPPC9, disrupted the interaction of TRAPPC8 with
SEC31A (Figure 7F). Thus, the two distinct mammalian TRAPP
complexes, defined by the presence of TRAPPC9/10 or
TRAPPC8/11/12/13, differentially interact with COPII (Figure 7H);
we refer to these as mTRAPPII and mTRAPPIII, respectively.
The two TRAPP complexes seem to have opposing roles in
ricin transport. Because we observe protection against ricin
with COPII or mTRAPPIII knockdowns and these components
interact physically, it is tempting to speculate that this complex
functions similarly to yeast TRAPPI in COPII vesicle tethering.
Additionally, TRAPPC8 knockdown has been reported to impact
flux through the autophagy pathway (Behrends et al., 2010), and
we observed a mild enhancement of toxin degradation upon
TRAPPC8 knockdown (Figure 6H), raising the possibility that
mTRAPPIII functions in both COPII-mediated trafficking and
autophagy. By contrast, TRAPPC9/10 was previously reported
to interact with COPI components (Yamasaki et al., 2009). More-
over, we find that both COPI and TRAPPC9 knockdown sensitize
cells to ricin, suggesting that mTRAPPII may function in tethering
of COPI vesicles. More generally, our findings establish that
there are functionally distinct mammalian TRAPP complexes
and lay the groundwork for a mechanistic understanding of their
specialized functions.
Perspective
Building on previous pooled shRNA strategies (e.g., Moffat et al.,
2006; Silva et al., 2005), we have developed an integrated plat-
form to functionally dissect complex biological processes in
mammalian cells using high-density genetic interaction maps.
Our strategy opens mammalian cell biology to the types of
systematic genetic analyses that have been highly successful
in microorganisms (Collins et al., 2009; Dixon et al., 2009).
Our first application of the platform elucidated key cellular
pathways and revealed how they modulate ricin susceptibility.
Our analysis of the TRAPP complex, in particular, illustrates
how genetic and physical interactions provide complementary
approaches to understand the functions of multiprotein com-
plexes, as our studies revealed two functionally distinct mamma-
lian TRAPP complexes.
A key aspect of our primary screening platform is the ability to
identify hit genes based on the likelihood that shRNAs act
through the intended target gene rather than solely the strength
and reproducibility of observed shRNA phenotypes. This is facil-
itated by the use of ultracomplex shRNA libraries that include
a large number of negative controls. Our approach also provides
a principled way to benchmark shRNA library design and
screening systems based not only on the strength of on-target
mRNA knockdown, but also by the ability to distinguish true
hits from background (e.g., off-target effects or statistical noise).
Using this criterion, we are currently exploring modifications to
the experimental strategy and shRNA design of our ultracomplex
libraries. Another important feature of ultracomplex libraries is(G) WDR11 and COPZ1 knockdown increase levels of ER-localized ricin as meas
ER-localized ricin; mean of triplicate experiments ± SD. The asterisks indicate sta
bars represent SD.
(H) Model: Ricin partitions between degradation and productive intoxication path
See also Figure S7.that they target each gene with a wide spectrum of shRNAs
with different knockdown strengths, effectively creating an allelic
series. This will facilitate the study of essential genes, as well as
gene dosage effects. Though our genetic interaction maps are
currently based on shRNAs identified in a primary screen, our
growing library of validated shRNAs will soon enable the
mapping of interactions between genes that do not have an
individual phenotype and the detection of synergistic genetic
interactions between them. Ongoing efforts by several groups
to identify effective shRNAs (Cheung et al., 2011; Fellmann
et al., 2011; Marcotte et al., 2012) will greatly facilitate the
construction of larger GI maps.
Our approach should be broadly applicable to the study of
complex biological systems. Although we present a pooled
screening strategy based on cell growth and viability, other
phenotypic readouts that physically separate cell populations
can be used, such as fluorescence-activated cell sorting or
migration assays. In addition, the ability to rapidly generate
and screen a double-shRNA library will allow one to explore
conservation and rewiring of genetic interactions in diverse cell
types and under different conditions (Bandyopadhyay et al.,
2010; M.K., M.C.B., and J.S.W., unpublished data).
The systematic exploration of genetic interactions in human
cells also has broad medical relevance, especially for cancer
biology and therapy. Functional surveys of genes in cancer cells
can distinguish oncogenic drivers from mere passengers.
Genetic interactions are thought to be crucial determinants of
properties of individual cancer cells (Ashworth et al., 2011),
such as their resistance to therapeutic agents. A better under-
standing of resistance pathways in specific genetic back-
grounds could pave the way for personalized combination
therapies that preemptively block the cancer’s escape routes.
More generally, as demonstrated for HIV, combination therapy
is a promising strategy to counter the problem of rapidly evolving
drug resistance in tumors. The ability to identify rare synthetic
lethal interactions between huge numbers of gene pairs maxi-
mizes the opportunity to identify pairs of drugs that synergisti-
cally target a disease state.
EXPERIMENTAL PROCEDURES
shRNA Libraries
To express shRNAs from a Pol II promoter in a miR30-derived context, we
adapted strategies developed by the Hannon and Elledge groups (Paddison
et al., 2004; Silva et al., 2005). Construction of pooled libraries was conducted
essentially as previously described (Bassik et al., 2009). The genome-wide
library was divided into nine sublibraries with 55,000 shRNA each and
targeted each human protein-coding gene with 25 independent shRNAs.
Each sublibrary also contained 500 or more negative control shRNAs, which
were designed to match the base composition of targeted shRNAs within
the same sublibrary without targeting any transcript in the human genome.
Table S2 contains the sequences of all primers used in this study, and Table
S3 includes target sequences of all active shRNAs used for follow-up
experiments.ured by the SNAP assay, whereas TRAPPC8 knockdown decreases levels of
tistically significant differences (**p < 0.01; ***p < 0.001; Student’s t test). Error
ways; inhibition of degradation increases productive intoxication.
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Figure 7. Functional Dissection of the TRAPP Complex
(A and B) All TRAPP complex members (other than TRAPPC9/10) specifically coimmunoprecipitate with TRAPPC11 (A) and TRAPPC8 (B), as quantified by mass
spectrometry.
(C) Correlation of genetic interactions with TRAPPC11 and buffering genetic interaction with TRAPPC11 are shown for each gene included in the genetic
interaction map. TRAPP complex members are shown in blue. TRAPPC9 (red) shows a strongly anticorrelated genetic interaction pattern when compared to
other TRAPP complex members.
(D) Abundance (quantified as LFQ) of each TRAPP subunit in the immunoprecipitation is indicated by color scale.
(E) Extracts from K562 cells were fractionated by size exclusion chromatography on a Superose 6 column. Western blot could detect comigration of TRAPPC8
and TRAPPC11, which were larger in size than TRAPPC10. The core component TRAPPC3 migrated with both components. EXT, unfractionated extract.
(F) Immunoprecipitation of TRAPPC8 or TRAPPC10 tagged with GFP showed specific association of TRAPPC8 with SEC31A.
(G) Association of GFP-TRAPPC8 with SEC31A was assessed by immunoprecipitation in extracts from cells stably expressing shRNAs targeting the indicated
TRAPP components.
(H) Hypothetical model for mammalian TRAPP complexes. We propose that at least two complexes exist, which contain a core set of proteins (yellow) and unique
subunits, either TRAPPC9/10 (mTRAPPII) or TRAPPC8/11/12/13 (mTRAPPIII), which associate with COPI or COPII vesicles, respectively.Ricin Resistance Screening
For pooled screens, cells were seeded at 0.5 3 106/ml at a representation of
1,000 cells/library element and were treated with 0.5 ng/ml ricin (Vector
labs), which reduced cell number by 50% compared with untreated cells
due to a combination of cell death and reduced growth rate. This selective
pressure represents a compromise between stronger selection, which can920 Cell 152, 909–922, February 14, 2013 ª2013 Elsevier Inc.increase the dynamic range of observed phenotypes, and weaker selection,
which reduces population bottlenecks and thus reduces Poisson sampling
noise. After 24 hr, ricin was washed out. Each day during the screen, cells
were diluted to 0.5 3 106/ml. After 2–3 days of recovery when treated cells
were again doubling at WT rate, a new cycle of ricin treatment was initiated
(total of four pulses). For competitive growth assays, cells were infected with
lentivirus-encoding individual shRNAs. After 3 days, cells were seeded in 24-
well plates at 0.5 3 106/ml and treated with 0.5 ng/ml ricin. After 24 hr, ricin
was washed out, and cells were adjusted to 0.5 3 106/ml. Percentages of
mCherry-positive cells were assessed by FACS 24–48 hr later.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, three
tables, and seven figures and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2013.01.030.ACKNOWLEDGMENTS
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